Stay updated on Tolebrutinib in NRSPMS Clinical Trial
Sign up to get notified when there's something new on the Tolebrutinib in NRSPMS Clinical Trial page.

Latest updates to the Tolebrutinib in NRSPMS Clinical Trial page
- Check6 days agoChange DetectedThe page now renders a 403 error instead of the study record content, making the trial information inaccessible on this page.SummaryDifference17%

- Check13 days agoChange DetectedThe Israel study locations were updated: the Qiryat Krinitzi site (52621) was removed and the Tel Litwinsky site (52621) was added, affecting enrollment options in the region.SummaryDifference0.1%

- Check20 days agoChange DetectedAdded Qiryat Krinitzi, Israel, 52621 as a new study site. Removed Tel Litwinsky, Israel, 52621 from the site list.SummaryDifference0.1%

- Check27 days agoChange DetectedA new revision tag, Revision: v3.6.6, was added, replacing the previous Revision: v3.6.5. This reflects an update to the page's revision metadata rather than substantive content changes.SummaryDifference0.0%

- Check48 days agoChange DetectedA new publication citation by Maxwell CR et al. regarding Tolebrutinib liver safety was added to the Publications section, and the page revision is updated to v3.6.5. The plain-language results summary, sponsor attribution text, and 'Helpful Links Provided by' were removed, and the revision tag was updated from v3.6.4.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision: v3.6.4 is now displayed on the page, replacing the previous Revision: v3.6.3. This update represents a minor metadata change and does not modify the study content or user-facing functionality.SummaryDifference0.0%

Stay in the know with updates to Tolebrutinib in NRSPMS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tolebrutinib in NRSPMS Clinical Trial page.